For: | Abbas Z, Abbas M. Management of hepatitis delta: Need for novel therapeutic options. World J Gastroenterol 2015; 21(32): 9461-9465 [PMID: 26327754 DOI: 10.3748/wjg.v21.i32.9461] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i32/9461.htm |
Number | Citing Articles |
1 |
Nathalie Mentha, Sophie Clément, Francesco Negro, Dulce Alfaiate. A review on hepatitis D: From virology to new therapies. Journal of Advanced Research 2019; 17: 3 doi: 10.1016/j.jare.2019.03.009
|
2 |
I. P. Balmasova, R. I. Sepiashvili, T. A. Slavyanskaya, E. S. Malova, Ya. R. Sepiashvili. COINFECTION BY HEPATITIS B AND HEPATITIS DELTA VIRUSES: MOLECULAR BIOLOGY OF PATHOGENS AND PROSPECTS OF PHARMACOTHERAPY. Journal of microbiology, epidemiology and immunobiology 2018; 95(2): 95 doi: 10.36233/0372-9311-2018-2-95-102
|
3 |
Hannah Nam, Kathy M. Nilles, Josh Levitsky, Michael G. Ison. Donor-derived Viral Infections in Liver Transplantation. Transplantation 2018; 102(11): 1824 doi: 10.1097/TP.0000000000002326
|
4 |
Grazia A Niro, Arianna Ferro, Francesca Cicerchia, Isabella Brascugli, Marilena Durazzo. Hepatitis delta virus: From infection to new therapeutic strategies. World Journal of Gastroenterology 2021; 27(24): 3530-3542 doi: 10.3748/wjg.v27.i24.3530
|
5 |
Nazish Butt, Muhammad T Usmani, Riaz Hussain, Saba Mughal, Fakhar A Qazi Arisar. Efficacy of Pegylated Interferon-alpha-2a in Chronic Hepatitis Delta: Experience from a Tertiary Care Hospital in Karachi. Euroasian journal of hepato-gastroenterology 2024; 14(1): 51 doi: 10.5005/jp-journals-10018-1431
|
6 |
David Tabernero, Maria Francesca Cortese, Maria Buti, Francisco Rodriguez-Frias. HDV evolution—will viral resistance be an issue in HDV infection?. Current Opinion in Virology 2018; 32: 100 doi: 10.1016/j.coviro.2018.10.003
|
7 |
Vanessa Zhu, Jürgen Burhenne, Johanna Weiss, Mathias Haag, Ute Hofmann, Matthias Schwab, Stephan Urban, Gerd Mikus, David Czock, Walter E. Haefeli, Antje Blank. Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1128547
|
8 |
Zakey Yusuf Buuh, Zhigang Lyu, Rongsheng E. Wang. Interrogating the Roles of Post-Translational Modifications of Non-Histone Proteins. Journal of Medicinal Chemistry 2018; 61(8): 3239 doi: 10.1021/acs.jmedchem.6b01817
|
9 |
Beatriz Pacin-Ruiz, María Francesca Cortese, David Tabernero, Sara Sopena, Josep Gregori, Selene García-García, Rosario Casillas, Adrián Najarro, Unai Aldama, Adriana Palom, Ariadna Rando-Segura, Anna Galán, Marta Vila, Mar Riveiro-Barciela, Josep Quer, Gloria González-Aseguinolaza, María Buti, Francisco Rodríguez-Frías. Inspecting the Ribozyme Region of Hepatitis Delta Virus Genotype 1: Conservation and Variability. Viruses 2022; 14(2): 215 doi: 10.3390/v14020215
|